Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Fact, overdiagnosis cannot be evaluated by comparing histological grading of prostate biopsy to prostatectomy specimen

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Martini A, Touzani A, Mazzone E, Roumiguié M, Marra G, Valerio M, et al. Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions. Prostate Cancer Prostatic Dis. 2022. https://doi.org/10.1038/s41391-022-00606-6.

  2. Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N. Engl J Med. 2016;375:1415–24.

    Article  Google Scholar 

  3. Boesen L, Nørgaard N, Løgager V, Balslev I, Bisbjerg R, Thestrup KC, et al. Prebiopsy biparametric magnetic resonance imaging combined with prostate-specific antigen density in detecting and ruling out Gleason 7–10 prostate cancer in biopsy-naïve men. Eur Urol Oncol. 2019; 2. https://doi.org/10.1016/j.euo.2018.09.001.

  4. Kawa SM, Stroomberg HV, Larsen SB, Helgstrand JT, Toft BG, Vickers AJ, et al. A nationwide analysis of risk of prostate cancer diagnosis and mortality following an initial negative TRUS-biopsy with long-term follow-up. J Urol. 2022;208:100–8.

    Article  Google Scholar 

  5. Hilscher M, Røder A, Helgstrand JT, Klemann N, Brasso K, Vickers AJ, et al. Risk of prostate cancer and death after benign transurethral resection of the prostate—A 20‐year population‐based analysis. Cancer. 2022;128:3674–3680.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: HVS, KB, AR; Writing – Original Draft: HVS; Writing – Review & Editing: HVS, KB, AR.

Corresponding author

Correspondence to Hein Vincent Stroomberg.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Stroomberg, H.V., Brasso, K. & Røder, A. Fact, overdiagnosis cannot be evaluated by comparing histological grading of prostate biopsy to prostatectomy specimen. Prostate Cancer Prostatic Dis (2022). https://doi.org/10.1038/s41391-022-00629-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41391-022-00629-z

Search

Quick links